Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.

Participants needed: 210
Trial details
Phase: Phase 2, Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Bluefin Biomedicine, Inc.Updated: May 29, 2026Locations: 58
Eligibility criteria

Are adults (18 to 75 years) with a diagnosis of hidradenitis suppurativa for at... [+2]

Have certain infections or other immune conditions. [+2]

Status: Recruiting

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.

Participants needed: 225
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Bluefin Biomedicine, Inc.Updated: May 29, 2026Locations: 88
Eligibility criteria

Are adults (18-75) with a diagnosis of atopic dermatitis for at least one year. [+2]

Have certain infections or other immune conditions. [+2]